Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Betapressin
2. Hoe 893d
3. Hoe-893d
4. Hoe893d
5. Penbutolol
6. Penbutolol Sulfate
7. Penbutolol Sulfate (2:1)
8. Sulfate, Penbutolol
1. Penbutolol Sulfate
2. Betapressin
3. 38363-32-5
4. Penbutolol Sulfate (200 Mg)
5. Hoe-893d
6. Hoe-39893d
7. Schembl41409
8. Chembl1200363
9. Pharmakon1600-01505567
10. Nsc760043
11. Ccg-213484
12. 363p325
Molecular Weight | 389.5 g/mol |
---|---|
Molecular Formula | C18H31NO6S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 7 |
Exact Mass | 389.18720888 g/mol |
Monoisotopic Mass | 389.18720888 g/mol |
Topological Polar Surface Area | 125 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 375 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Levatol |
PubMed Health | Penbutolol (By mouth) |
Drug Classes | Antianginal, Antihypertensive, Cardiovascular Agent |
Drug Label | levatol (penbutolol sulfate) is a synthetic -receptor antagonist for oral administration. The chemical name of penbutolol sulfate is (S)-1-tert-butylamino-3-(o-cyclopentylphenoxy)-2-propanol sulfate. It is provided as the levorotatory isomer. The... |
Active Ingredient | Penbutolol sulfate |
Dosage Form | Tablet |
Route | Oral |
Strength | 20mg |
Market Status | Prescription |
Company | Auxilium Pharms |
2 of 2 | |
---|---|
Drug Name | Levatol |
PubMed Health | Penbutolol (By mouth) |
Drug Classes | Antianginal, Antihypertensive, Cardiovascular Agent |
Drug Label | levatol (penbutolol sulfate) is a synthetic -receptor antagonist for oral administration. The chemical name of penbutolol sulfate is (S)-1-tert-butylamino-3-(o-cyclopentylphenoxy)-2-propanol sulfate. It is provided as the levorotatory isomer. The... |
Active Ingredient | Penbutolol sulfate |
Dosage Form | Tablet |
Route | Oral |
Strength | 20mg |
Market Status | Prescription |
Company | Auxilium Pharms |
Adrenergic beta-Antagonists
Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Penbutolol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Penbutolol, including repackagers and relabelers. The FDA regulates Penbutolol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Penbutolol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Penbutolol supplier is an individual or a company that provides Penbutolol active pharmaceutical ingredient (API) or Penbutolol finished formulations upon request. The Penbutolol suppliers may include Penbutolol API manufacturers, exporters, distributors and traders.
click here to find a list of Penbutolol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Penbutolol DMF (Drug Master File) is a document detailing the whole manufacturing process of Penbutolol active pharmaceutical ingredient (API) in detail. Different forms of Penbutolol DMFs exist exist since differing nations have different regulations, such as Penbutolol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Penbutolol DMF submitted to regulatory agencies in the US is known as a USDMF. Penbutolol USDMF includes data on Penbutolol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Penbutolol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Penbutolol suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Penbutolol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Penbutolol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Penbutolol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Penbutolol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Penbutolol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Penbutolol suppliers with NDC on PharmaCompass.
Penbutolol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Penbutolol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Penbutolol GMP manufacturer or Penbutolol GMP API supplier for your needs.
A Penbutolol CoA (Certificate of Analysis) is a formal document that attests to Penbutolol's compliance with Penbutolol specifications and serves as a tool for batch-level quality control.
Penbutolol CoA mostly includes findings from lab analyses of a specific batch. For each Penbutolol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Penbutolol may be tested according to a variety of international standards, such as European Pharmacopoeia (Penbutolol EP), Penbutolol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Penbutolol USP).
LOOKING FOR A SUPPLIER?